DRNA लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 05:30):

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals...

Stats
आज की मात्रा	5.54M
औसत मात्रा	3.03M
बाजार मूल्य	0.00
EPS	$-0.220 ( Q3 \| 2021-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.989 (2.59%)

AADI -2.65%

ABCL 1.47%

ABCM 0.04%

ABEO -2.37%

ABIO -1.68%

ABOS 1.64%

ABSI 3.07%

ABUS -2.24%

ABVX -3.53%

ACAD -0.54%

ACER -17.95%

ACET -4.44%

ACGN 1.29%

ACHL -4.15%

ACHV -1.72%

ACIU -0.50%

ACLX -0.09%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.59%

ADPT -0.30%

ADTX -3.47%

ADVM -4.29%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.54%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.25%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.47%

ALLO -6.47%

ALLR -3.17%

ALNA 3.16%

ALNY 1.80%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.34%

ALVR -0.58%

ALXN 0.00%

ALXO -10.65%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.50%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.65%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS -0.02%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.70%

ARDS -14.23%

ARDX -0.58%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.50%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.19%

ARWR -1.86%

ASLN -4.71%

ASMB -7.01%

ASND -0.91%

ATAI -1.46%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.72%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.86%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.77%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.32%

BCTX 8.12%

BCTXW -22.52%

BCYC 0.85%

BDRX -4.65%

BDTX -0.70%

BEAM 0.24%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 1.27%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.54%

BMEA -9.79%

BMRN 0.36%

BNOX -2.22%

BNTC -2.11%

BNTX -1.26%

BOLD -7.90%

BOLT -0.18%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.46%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.35%

CADL -0.97%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.40%

CARA -0.63%

CARM 12.16%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.40%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.48%

CELC -3.85%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.86%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -2.79%

CGON -0.29%

CGTX -5.11%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING -3.70%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.27%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.24%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -0.91%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.89%

CORT 2.17%

COYA -1.46%

CPRX -0.76%

CRBP -1.89%

CRBU -4.56%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.55%

CRSP 1.03%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -0.65%

CTXR 0.04%

CUE 3.53%

CVAC -2.25%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.01%

CYTO -2.73%

DARE 7.54%

DAWN 0.75%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 33.43%

DNLI -1.85%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.41%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -4.30%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.57%

ETON 1.49%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.51%

EYPT -0.12%

FATE -8.05%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.60%

FBRX -0.04%

FDMT -4.72%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.47%

FULC -3.35%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.29%

GANX -0.78%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -1.60%

GLMD -2.15%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.00%

GNTA 3.94%

GOSS -8.81%

GOVX 3.65%

GOVXW -49.04%

GPCR -6.51%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.00%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -0.89%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.83%

HRTX 1.64%

HSTO 0.00%

HUMA 1.01%

HUMAW -0.01%

IBRX -4.26%

ICCC 0.22%

ICPT 0.21%

ICU 17.92%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.52%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.70%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.77%

INAB 0.59%

INBX 0.47%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.80%

INSM -0.82%

INTS -2.75%

INVA 0.22%

INZY 1.14%

IOBT -11.02%

IONS 0.15%

IOVA -2.25%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.44%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.22%

JAZZ -0.55%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.71%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.79%

KTRA 15.99%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.22%

KYTX -3.50%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.93%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.01%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.87%

LPCN -3.16%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.50%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.91%

LYRA 2.71%

MACK 0.10%

MBIO -9.40%

MBRX -1.72%

MCRB 1.12%

MDGL -2.42%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.68%

MGX -2.68%

MIRM -1.16%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.62%

MNKD -0.86%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.67%

MREO -4.42%

MRKR 2.68%

MRNA -4.91%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.18%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.98%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.72%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.46%

NMTR -42.97%

NOVN -24.84%

NRBO 10.92%

NRIX -0.58%

NRSN -6.16%

NRSNW 0.00%

NRXP -4.14%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.21%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.79%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -2.99%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -1.91%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.20%

OMER -0.90%

OMGA 5.42%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -4.53%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.64%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -1.11%

PEPG 0.48%

PGEN -3.01%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.95%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.31%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 2.61%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.84%

QSIAW -3.13%

QTTB -4.54%

QURE -0.45%

RAIN -1.63%

RANI 6.42%

RAPT -2.29%

RARE 1.10%

RCKT -8.09%

REGN -0.66%

RENB -3.11%

REPL -2.82%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.59%

RLMD 0.33%

RLYB -0.34%

RNA -0.42%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.32%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.07%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.41%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.06%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.09%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -2.17%

SGTX -2.56%

SIOX 22.63%

SLDB -5.09%

SLGL 4.00%

SLN -4.01%

SLNO -2.92%

SLRX 5.23%

SLS -2.99%

SMMT -2.62%

SNDX 0.82%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.85%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -4.80%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.42%

SWTX 0.72%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.12%

TBPH 0.48%

TCBP 2.73%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.21%

TENX -1.27%

TERN -7.59%

TFFP -3.05%

TGTX -2.71%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.35%

TNYA -8.76%

TPST 2.30%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -24.09%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -7.24%

UBX -2.12%

UNCY -3.38%

URGN -1.45%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.81%

VERU 0.78%

VERV -3.05%

VIGL 5.11%

VINC 1.62%

VIR 0.43%

VIRI -1.57%

VIRX 2.40%

VKTX -1.34%

VLON -13.04%

VNDA -2.36%

VOR -2.02%

VRCA 0.28%

VRDN -4.23%

VRNA -1.00%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.60%

XBIO 0.93%

XBIT 0.21%

XCUR 3.58%

XENE -2.91%

XERS 2.38%

XFOR 3.71%

XLO 1.58%

XLRN 0.00%

XNCR 0.34%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2021-12-28	Koppel Adam	Sell	3 080 237	Common Stock
2021-12-28	Koppel Adam	Sell	3 333	Restricted Stock Units
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 12 087 \| Sell: 8 528 928

मात्रा सहसंबंध

लंबा: 0.55 (weak)

छोटा: 0.93 (very strong)

Signal:(82.281) Expect same movement, but be aware

Dicerna Pharmaceuticals सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
ADMS	0.97
QADB	0.913
TYHT	0.901
DCRCU	0.898
FLXN	0.885
APOP	0.864
CNST	0.858
CNBKA	0.854
LCYAU	0.846
ICON	0.824

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Dicerna Pharmaceuticals सहसंबंध - मुद्रा/वस्त्र

0.35
( neutral )

-0.50
( neutral )

0.85
( strong )

0.45
( neutral )

-0.30
( neutral )

-0.64
( weak negative )

Dicerna Pharmaceuticals वित्तीय

Annual	2020
राजस्व:	$164.31M
सकल लाभ:	$164.31M (100.00 %)
EPS:	$-1.520

FY	2020
राजस्व:	$164.31M
सकल लाभ:	$164.31M (100.00 %)
EPS:	$-1.520

FY	2019
राजस्व:	$23.90M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.760

FY	2018
राजस्व:	$6.18M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.600

Financial Reports:

No articles found.

Dicerna Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dicerna Pharmaceuticals

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk A/S.